Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000539 |
---|---|
Receipt number | R000000656 |
Scientific Title | PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation |
Date of disclosure of the study information | 2006/12/11 |
Last modified on | 2016/04/20 09:39:01 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2006/12/06 14:18:40 | ||
2 | Update | 2008/05/28 11:04:57 | Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address Name of person sending information Organization Division name Address Institute Institute Organization Organization |
|
3 | Update | 2008/06/09 13:38:19 | Key inclusion criteria Key inclusion criteria |
|
4 | Update | 2008/06/09 13:40:02 | ||
5 | Update | 2009/09/29 12:08:02 | Recruitment status |
|
6 | Update | 2010/06/08 16:54:31 | Last follow-up date |
|
7 | Update | 2013/01/07 10:14:07 | Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. Email1 |
|
8 | Update | 2013/07/08 19:11:57 | Organization Organization Division name Division name Address Address TEL |
|
9 | Update | 2014/06/06 09:09:58 | Recruitment status |
|
10 | Update | 2014/09/05 11:46:11 | Email Name of person sending information Name of person sending information |
|
11 | Update | 2014/09/05 11:49:19 | Name of person sending information Name of person sending information |
|
12 | Update | 2015/08/31 16:01:38 | Publication of results URL related to results and publications |
|
13 | Update | 2015/09/10 16:25:19 | URL related to results and publications |
|
14 | Update | 2016/04/20 09:39:01 | Recruitment status |